Company Name : Galen pharmaceuticals limited
Address : Mr. Harsh Patel (Marketing Manger), No. 334/5, G. I. D. C. Estate, Waghodia, Vadodara – 391760, Gujarat, India
Tel No: 09953363274, (91)-9825247599
Email : galen_pharma@yahoo.com, galenpharma10@gmail.com
Website : http://www.galenpharmaceuticals.com/
Company Profile
We are an ISO 9001:2008 certified company. Established in the year 1990, we “Galen Pharmaceuticals Limited” is a name to reckon with, when it comes to manufacturing, supplying and exporting a wide range of Tablet & Suppositoey. In which includes Pharmaceutical Suppositories, Pharmaceutical Tablet & Pharmaceutical Medicine. We have equipped a separate unit for quality measures of our product line to meet the international standards. Our precious clients can avail these products from us at industry leading prices.
We are supported with a sophisticated infrastructural facility that spreads over a large area assists us to manufacture bulk products in order to meet various requirements of market within a promised time frame. We are highly appreciated amongst our clients at both international and domestic level. Total commitment and quality consistency has been one of the major reasons behind the growth and success of our organization. With our state-of-the-art processing unit and painstaking efforts made by our team, we are able to offer our clients with highly effective and accurately comprises medicines.
We are headed by our mentor, Mr. Harsh Patel. His sharp business insight and profound knowledge have helped us gain a commendable position in the areas like South Africa, East Africa, UK & Nigeria..
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…